Elisa Waldmann

740 total citations
34 papers, 561 citations indexed

About

Elisa Waldmann is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Elisa Waldmann has authored 34 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Physiology. Recurrent topics in Elisa Waldmann's work include Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Child Nutrition and Water Access (5 papers). Elisa Waldmann is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Child Nutrition and Water Access (5 papers). Elisa Waldmann collaborates with scholars based in Germany, United States and China. Elisa Waldmann's co-authors include Klaus G. Parhofer, WU Li-ya, Renée Stark, Katharina Lechner, Terence F. McGuire, Charles M. Wilhelmj, Sandra E. Fischer, Christos S. Mantzoros, Berthold Koletzko and Hans Demmelmair and has published in prestigious journals such as Gastroenterology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Elisa Waldmann

32 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Waldmann Germany 13 206 172 105 96 88 34 561
Maire Rantala Finland 13 192 0.9× 71 0.4× 167 1.6× 146 1.5× 113 1.3× 15 640
F. Abello Italy 11 227 1.1× 85 0.5× 99 0.9× 66 0.7× 69 0.8× 15 451
Annika Bylund Sweden 8 116 0.6× 77 0.4× 81 0.8× 103 1.1× 35 0.4× 9 570
O Mantero Italy 7 161 0.8× 185 1.1× 112 1.1× 77 0.8× 116 1.3× 20 657
Anisa Jahangiri United States 14 260 1.3× 180 1.0× 189 1.8× 92 1.0× 120 1.4× 19 671
Kristin L. Herron United States 11 124 0.6× 115 0.7× 145 1.4× 190 2.0× 50 0.6× 12 640
Isabel Megías-Rangil Spain 6 73 0.4× 105 0.6× 69 0.7× 156 1.6× 66 0.8× 9 508
Yu. I. Ragino Russia 11 119 0.6× 83 0.5× 86 0.8× 88 0.9× 140 1.6× 164 668
Edward N. Siguel United States 8 93 0.5× 419 2.4× 79 0.8× 135 1.4× 29 0.3× 10 602
Ana I. Perez‐Caballero Spain 10 75 0.4× 108 0.6× 101 1.0× 160 1.7× 83 0.9× 11 571

Countries citing papers authored by Elisa Waldmann

Since Specialization
Citations

This map shows the geographic impact of Elisa Waldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Waldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Waldmann more than expected).

Fields of papers citing papers by Elisa Waldmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Waldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Waldmann. The network helps show where Elisa Waldmann may publish in the future.

Co-authorship network of co-authors of Elisa Waldmann

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Waldmann. A scholar is included among the top collaborators of Elisa Waldmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Waldmann. Elisa Waldmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waldmann, Elisa, et al.. (2022). Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia). PLoS ONE. 17(3). e0265838–e0265838. 9 indexed citations
2.
3.
Waldmann, Elisa. (2020). Lipidtherapie bei Diabetikern — ein Update. MMW - Fortschritte der Medizin. 162(8). 38–42. 1 indexed citations
4.
Waldmann, Elisa. (2019). So behandeln Sie den Steroiddiabetes richtig. MMW - Fortschritte der Medizin. 161(9). 51–54.
5.
Kohli, Rohit, Vlad Ratziu, Maria Isabel Fiel, et al.. (2019). Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group. Molecular Genetics and Metabolism. 129(2). 59–66. 16 indexed citations
6.
Waldmann, Elisa & Klaus G. Parhofer. (2019). Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a). Pathology. 51(2). 227–232. 25 indexed citations
7.
Lechner, Katharina, WU Li-ya, Elisa Waldmann, et al.. (2018). A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial. Nutrients. 10(2). 244–244. 101 indexed citations
8.
9.
Li-ya, WU, et al.. (2017). THE EFFECT OF PCSK9 INHIBITION ON LDL-SUBFRACTIONS IN PATIENTS WITH SEVERE LDL-HYPERCHOLESTEROLEMIA. Journal of the American College of Cardiology. 69(11). 1719–1719. 4 indexed citations
10.
11.
Waldmann, Elisa, et al.. (2017). Statin intolerance is the main indication for PCSK9 inhibition in clinical practice. Atherosclerosis. 263. e80–e80. 3 indexed citations
12.
Waldmann, Elisa & Klaus G. Parhofer. (2016). Lipoprotein apheresis to treat elevated lipoprotein (a). Journal of Lipid Research. 57(10). 1751–1757. 82 indexed citations
13.
Julius, Ulrich, Mark Milton, Daniel J. Rader, et al.. (2015). Effects of lipoprotein apheresis on PCSK9 levels. Atherosclerosis Supplements. 18. 180–186. 17 indexed citations
14.
Lechner, Katharina, Benedikt A. Aulinger, Stephan Brand, Elisa Waldmann, & Klaus G. Parhofer. (2015). Hydrothermally modified slow release corn starch: a potential new therapeutic option for treating hypoglycemia in autoimmune hypoglycemia (Hirata’s disease). European Journal of Clinical Nutrition. 69(12). 1369–1370. 9 indexed citations
15.
Li-ya, WU, Elisa Waldmann, Uli C. Broedl, et al.. (2013). Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: A randomized controlled cross-over clinical trial. Metabolism. 63(3). 382–391. 70 indexed citations
16.
Waldmann, Elisa, Thomas P. Hüttl, Burkhard Göke, Reinhold A. Lang, & Klaus G. Parhofer. (2013). Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients. Lipids in Health and Disease. 12(1). 17 indexed citations
17.
Waldmann, Elisa. (1960). Child wastage, due to malnutrition in Sekhukuniland.. Central African Journal of Medicine. 6(7). 298–301. 4 indexed citations
18.
Wilhelmj, Charles M., Elisa Waldmann, & Terence F. McGuire. (1951). Basal Blood Pressure of Normal Dogs Determined by an Auscultatory Method and a Study of the Effect of Fasting. American Journal of Physiology-Legacy Content. 166(2). 296–303. 15 indexed citations
19.
Wilhelmj, Charles M., Elisa Waldmann, & Terence F. McGuire. (1951). Effect of Prolonged High Sodium Chloride Ingestion and Withdrawal upon Blood Pressure of Dogs.. Experimental Biology and Medicine. 77(3). 379–382. 6 indexed citations
20.
Wilhelmj, Charles M., Elisa Waldmann, & Terence F. McGuire. (1951). Basal Blood Pressure of Normal Dogs Determined by an Auscultatory Method and a Study of the Effect of Fasting. American Journal of Physiology-Legacy Content. 167(3). 840–840. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maire Rantala Breakdown of academic impact, for papers by F. Abello Breakdown of academic impact, for papers by Annika Bylund Breakdown of academic impact, for papers by O Mantero Breakdown of academic impact, for papers by Anisa Jahangiri Breakdown of academic impact, for papers by Kristin L. Herron Breakdown of academic impact, for papers by Isabel Megías-Rangil Breakdown of academic impact, for papers by Yu. I. Ragino Breakdown of academic impact, for papers by Edward N. Siguel Breakdown of academic impact, for papers by Ana I. Perez‐Caballero
Rankless by CCL
2026